NxThera
NxThera
Developer of minimally invasive thermal water vapor therapy for treating benign prostatic hyperplasia (BPH).
About
What does NxThera do?
NxThera developed the Rezūm System, a medical device that uses convective water vapor energy to treat benign prostatic hyperplasia (BPH) in a minimally invasive, office-based procedure. The company focused on improving patient quality of life by providing an alternative to traditional surgery or long-term medication for prostate conditions.
What is NxThera's revenue?
StartupHub estimates NxThera's annual revenue at $16.7B (range $9.4B to $22.7B, 65% confidence), based on comparable companies in the sector.
What is NxThera's valuation?
StartupHub estimates NxThera's effective valuation at $12.4M (range $8.1M to $19.5M, 10% confidence), based on comparable companies in the sector.
How much funding has NxThera raised?
NxThera has raised a total of $3M in funding. The most recent round on record is Series A.
Where is NxThera headquartered?
NxThera is headquartered in Maple Grove, United States.
When was NxThera founded?
NxThera was founded in 2008.
What industry does NxThera operate in?
NxThera operates in Medical Devices, Urology, HealthTech.
How many employees does NxThera have?
NxThera has approximately 53158 people on record.
No comments yet. Be the first to share your take.